$Treatment-related toxicity of hypofractionated radiation therapy for prostate cancer$

Treatment-related toxicity of hypofractionated radiation therapy for prostate cancer

Bibliographic Details
Main Authors:	A. Sujenthiran, M.G. Parry, J. Nossiter, P. Cathcart, N. Clarke, H. Payne, J. Van Der Meulen, A. Aggarwal
Format:	Article
Language:	English
Published:	Elsevier 2020-07-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168320340325

Similar Items

Patient-reported outcomes after prostate only vs. prostate and pelvic lymph node radiation therapy
by: M.G. Parry, et al.
Published: (2020-07-01)

Patient-reported outcomes following a high-dose rate brachytherapy boost for prostate cancer
by: M.G. Parry, et al.
Published: (2020-07-01)

TOXICITY OF HYPOFRACTIONATED RADIATION THERAPY FOR LOCALLY ADVANCED PROSTATE CANCER
by: Kushnerova E. V., et al.
Published: (2019-09-01)

Comparison of complications after transrectal and transperineal prostate biopsy: A national population-based study
by: B. Berry, et al.
Published: (2020-07-01)

Trends and variations in risk stratified prostate cancer management: A cross-sectional study of the National Prostate Cancer Audit database using the Cambridge Prognostic Group criteria
by: M.G. Parry, et al.
Published: (2020-07-01)

Patient-reported urinary incontinence following radical prostatectomy for prostate cancer and its association with undergoing incontinence surgery: A national population-based study
by: M.G. Parry, et al.
Published: (2020-07-01)

Risk stratification for prostate cancer management: value of the Cambridge Prognostic Group classification for assessing treatment allocation
by: M. G. Parry, et al.
Published: (2020-05-01)

Outcomes and toxicity from a prospective study of moderately hypofractionated radiation therapy for prostate cancer
by: Wei Gang Wang, MD, et al.
Published: (2018-04-01)

Early toxicity of hypofractionated radiotherapy for prostate cancer
by: Pavel Krupa, et al.
Published: (2016-09-01)

Acute toxicity in moderate hypofractionation with Simultaneous Integrated Boost (SIB) radiation therapy for prostate cancer: A prospective study
by: F. Kraja, et al.
Published: (2020-11-01)

Hypofractionated Postmastectomy Radiation Therapy
by: Mutlay Sayan, MD, et al.
Published: (2021-01-01)

Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer
by: Ju Andrew W, et al.
Published: (2013-01-01)

Hypofractionated radiation therapy after radical mastectomy: predictive factors of acute skin toxicity
by: R. Ben Amor, et al.
Published: (2021-04-01)

Hypofractionated Radiation Therapy for Large Brain Metastases
by: Giuseppina Laura Masucci
Published: (2018-10-01)

The Financial Impact of Hypofractionated Radiation for Localized Prostate Cancer in the United States
by: Assaf Moore, et al.
Published: (2019-01-01)

Vestibular Schwannoma: Results of Hypofractionated Stereotactic Radiation Therapy
by: Pierre-Marie Pialat, MD, et al.
Published: (2021-07-01)

Low Incidence of Fatigue after Hypofractionated Stereotactic Body Radiation Therapy (SBRT) for Localized Prostate Cancer
by: Chiranjeev eDash, et al.
Published: (2012-10-01)

Normal tissue toxicity after small field hypofractionated stereotactic body radiation
by: Constine Louis S, et al.
Published: (2008-10-01)

Economic evaluation of postoperative hypofractionated radiation therapy in patients with breast cancer
by: G. V. Afonin, et al.
Published: (2018-08-01)

EFFICACY OF HYPOFRACTIONATED ADJUVANT RADIATION THERAPY IN PATIENTS WITH OPERABLE BREAST CANCER
by: G. V. Afonin, et al.
Published: (2018-11-01)

Optimizing Timing of Immunotherapy Improves Control of Tumors by Hypofractionated Radiation Therapy.
by: Kristina H Young, et al.
Published: (2016-01-01)

A Dosimetric Comparison between Conventional Fractionated and Hypofractionated Image-guided Radiation Therapies for Localized Prostate Cancer
by: Ming Li, et al.
Published: (2016-01-01)

Long-term economic value of hypofractionated prostate radiation: Secondary analysis of a randomized trial
by: K. Ranh Voong, MD MPH, et al.
Published: (2017-07-01)

Long-term results of a phase II study of hypofractionated proton therapy for prostate cancer: moderate versus extreme hypofractionation
by: Boram Ha, et al.
Published: (2019-01-01)

Absence of toxicity with hypofractionated 3-dimensional radiation therapy for inoperable, early stage non-small cell lung cancer
by: Vuong Te, et al.
Published: (2006-11-01)

Hypofractionated postoperative helical tomotherapy in prostate cancer: a mono-institutional report of toxicity and clinical outcomes
by: Cuccia F, et al.
Published: (2018-10-01)

A pilot study of highly hypofractionated intensity-modulated radiation therapy over 3 weeks for localized prostate cancer
by: Nakamura, Kiyonao
Published: (2019)

Successful treatment of early cutaneous squamous cell carcinoma with hypofractionated radiation therapy in an African lion (Panthera leo)
by: Louise van der Weyden, et al.
Published: (2021-06-01)

Image Guided Hypofractionated Radiotherapy by Helical Tomotherapy for Prostate Carcinoma: Toxicity and Impact on Nadir PSA
by: Salvina Barra, et al.
Published: (2014-01-01)

Early Tolerance Outcomes of Stereotactic Hypofractionated Accelerated Radiation Therapy Concomitant with Pelvic Node Irradiation in High-risk Prostate Cancer
by: Attapol Pinitpatcharalert, MD, et al.
Published: (2019-04-01)

Moderately Hypofractionated Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost for Prostate Cancer: Five-Year Toxicity Results From a Prospective Phase I/II Trial
by: Anthony Ricco, et al.
Published: (2020-08-01)

Hypofractionated External-Beam Radiotherapy for Prostate Cancer
by: L. Chinsoo Cho, et al.
Published: (2013-01-01)

Extreme Hypofractionation with SBRT in Localized Prostate Cancer
by: Maria Antonia Gómez-Aparicio, et al.
Published: (2021-08-01)

Hypofractionation in Prostate Cancer: Radiobiological Basis and Clinical Appliance
by: M. Mangoni, et al.
Published: (2014-01-01)

Comparing two strategies of dynamic intensity modulated radiation therapy (dIMRT) with 3-dimensional conformal radiation therapy (3DCRT) in the hypofractionated treatment of high-risk prostate cancer
by: Yartsev Slav, et al.
Published: (2008-01-01)

Dose-Escalated Hypofractionated Intensity-Modulated Radiotherapy in High-Risk Carcinoma of the Prostate: Outcome and Late Toxicity
by: David Thomson, et al.
Published: (2012-01-01)

Accelerated hypofractionated radiation therapy compared to conventionally fractionated radiation therapy for the treatment of inoperable non-small cell lung cancer
by: Amini Arya, et al.
Published: (2012-03-01)

Acute Cardiotoxicity With Concurrent Trastuzumab and Hypofractionated Radiation Therapy in Breast Cancer Patients
by: Mutlay Sayan, et al.
Published: (2019-10-01)

Radiation Therapy for Palliation of Sarcoma Metastases: A Unique and Uniform Hypofractionation Experience
by: Viacheslav Soyfer, et al.
Published: (2010-01-01)

Reirradiation of head and neck cancer focusing on hypofractionated stereotactic body radiation therapy
by: Ogita Mikio, et al.
Published: (2011-08-01)